Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-04-29 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-03-19 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
ATHA | Athira Pharma | 19.18 | -0.11 | -0.57% | 699.8M |
You can purchase shares of Athira Pharma (NASDAQ: ATHA) through any online brokerage.
There are no as such competitors for Athira Pharma.
The latest price target for Athira Pharma (NASDAQ: ATHA) was reported by Jefferies on 2020-10-13. The analyst firm set a price target for 30.00 expecting ATHA to rise to within 12 months (a possible 56.41% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Athira Pharma (NASDAQ: ATHA) is $19.18 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Athira Pharma.
There is no upcoming split for Athira Pharma.